Learn More
Medchemexpress LLC STAT3-IN-15 | 3037596-35-0 | C20H17F3N2O3S | 1 ML

Supplier: Medchemexpress LLC HY15197610MM/1ML
STAT3-IN-15 is a potent and orally active STAT3 inhibitor effective against idiopathic pulmonary fibrosis (IPF). It inhibits STAT3 phosphorylation and also hinders the migration and deformation of epithelial cells induced by TGF-β1, consequently inhibiting epithelial-mesenchymal transition (EMT).
- Inhibits NIH-3T3 cell proliferation (IC50 of 0.47 μM).
- Forms hydrogen bonds with Lys591 and Ser636 in STAT3.
- Inhibits fibroblast activation and proliferation.
- Blocks TGF-β1 induced EMT process in A549 cells.
- Alleviates bleomycin-induced pulmonary fibrosis in mice.
- Recovers lung structure and reduces hydroxyproline content.
- Reduces p-Stat3Ty705 protein expression in lung tissue.
- Improves bleomycin-induced immune microenvironment imbalance.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.